Cargando…

Anti-neutrophil extracellular trap antibody in a patient with relapse of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report

BACKGROUND: Neutrophil extracellular traps (NETs) are web-like DNA decorated with antimicrobial proteins, such as myeloperoxidase (MPO), which are extruded from activated neutrophils. Although NETs are essential in innate immunity, an excessive formation of NETs has adverse effects, e.g., induction...

Descripción completa

Detalles Bibliográficos
Autores principales: Shida, Haruki, Hashimoto, Nobuhiro, Kusunoki, Yoshihiro, Hattanda, Fumihiko, Ogawa, Yayoi, Hayashi, Terumasa, Nakazawa, Daigo, Masuda, Sakiko, Tomaru, Utano, Ishizu, Akihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013953/
https://www.ncbi.nlm.nih.gov/pubmed/29929470
http://dx.doi.org/10.1186/s12882-018-0953-y
_version_ 1783334129366990848
author Shida, Haruki
Hashimoto, Nobuhiro
Kusunoki, Yoshihiro
Hattanda, Fumihiko
Ogawa, Yayoi
Hayashi, Terumasa
Nakazawa, Daigo
Masuda, Sakiko
Tomaru, Utano
Ishizu, Akihiro
author_facet Shida, Haruki
Hashimoto, Nobuhiro
Kusunoki, Yoshihiro
Hattanda, Fumihiko
Ogawa, Yayoi
Hayashi, Terumasa
Nakazawa, Daigo
Masuda, Sakiko
Tomaru, Utano
Ishizu, Akihiro
author_sort Shida, Haruki
collection PubMed
description BACKGROUND: Neutrophil extracellular traps (NETs) are web-like DNA decorated with antimicrobial proteins, such as myeloperoxidase (MPO), which are extruded from activated neutrophils. Although NETs are essential in innate immunity, an excessive formation of NETs has adverse effects, e.g., induction of anti-neutrophil cytoplasmic antibody (ANCA), to the hosts. Since ANCA can induce NET formation in the primed neutrophils, a positive feedback loop can be formed between NETs and ANCA, which is called “ANCA-NETs vicious cycle.” CASE PRESENTATION: A 79-year-old Japanese woman developed hydralazine-induced pauci-immune necrotizing crescentic glomerulonephritis with MPO-ANCA. Although the illness improved after cessation of hydralazine, MPO-ANCA-associated vasculitis relapsed 16 months later. Remission was achieved 5 months after beginning of administration of prednisone. In order to determine the involvement of ANCA-NETs vicious cycle in this patient, we examined NET degradation and induction activities in sera obtained at the disease onset (Serum A; MPO-ANCA, 107 IU/ml), at relapse (Serum B; MPO-ANCA, 195 IU/ml), at 3 months after treatment (Serum C; MPO-ANCA, 4.5 IU/ml), and at remission (Serum D; MPO-ANCA, 2.4 IU/ml). NET degradation activity was low in the all sera. NET induction activity was high in Sera A, B, and C but not in D. Additionally, we demonstrated the presence of anti-NET antibody (ANETA) in Sera B and C but not in A or D. CONCLUSIONS: The collective findings suggest NET induction potential of ANETA in the present patient and that the ANETA could contribute to the enhancement of NETs resulting in amplification of the ANCA-NETs vicious cycle.
format Online
Article
Text
id pubmed-6013953
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60139532018-07-05 Anti-neutrophil extracellular trap antibody in a patient with relapse of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report Shida, Haruki Hashimoto, Nobuhiro Kusunoki, Yoshihiro Hattanda, Fumihiko Ogawa, Yayoi Hayashi, Terumasa Nakazawa, Daigo Masuda, Sakiko Tomaru, Utano Ishizu, Akihiro BMC Nephrol Case Report BACKGROUND: Neutrophil extracellular traps (NETs) are web-like DNA decorated with antimicrobial proteins, such as myeloperoxidase (MPO), which are extruded from activated neutrophils. Although NETs are essential in innate immunity, an excessive formation of NETs has adverse effects, e.g., induction of anti-neutrophil cytoplasmic antibody (ANCA), to the hosts. Since ANCA can induce NET formation in the primed neutrophils, a positive feedback loop can be formed between NETs and ANCA, which is called “ANCA-NETs vicious cycle.” CASE PRESENTATION: A 79-year-old Japanese woman developed hydralazine-induced pauci-immune necrotizing crescentic glomerulonephritis with MPO-ANCA. Although the illness improved after cessation of hydralazine, MPO-ANCA-associated vasculitis relapsed 16 months later. Remission was achieved 5 months after beginning of administration of prednisone. In order to determine the involvement of ANCA-NETs vicious cycle in this patient, we examined NET degradation and induction activities in sera obtained at the disease onset (Serum A; MPO-ANCA, 107 IU/ml), at relapse (Serum B; MPO-ANCA, 195 IU/ml), at 3 months after treatment (Serum C; MPO-ANCA, 4.5 IU/ml), and at remission (Serum D; MPO-ANCA, 2.4 IU/ml). NET degradation activity was low in the all sera. NET induction activity was high in Sera A, B, and C but not in D. Additionally, we demonstrated the presence of anti-NET antibody (ANETA) in Sera B and C but not in A or D. CONCLUSIONS: The collective findings suggest NET induction potential of ANETA in the present patient and that the ANETA could contribute to the enhancement of NETs resulting in amplification of the ANCA-NETs vicious cycle. BioMed Central 2018-06-22 /pmc/articles/PMC6013953/ /pubmed/29929470 http://dx.doi.org/10.1186/s12882-018-0953-y Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Shida, Haruki
Hashimoto, Nobuhiro
Kusunoki, Yoshihiro
Hattanda, Fumihiko
Ogawa, Yayoi
Hayashi, Terumasa
Nakazawa, Daigo
Masuda, Sakiko
Tomaru, Utano
Ishizu, Akihiro
Anti-neutrophil extracellular trap antibody in a patient with relapse of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report
title Anti-neutrophil extracellular trap antibody in a patient with relapse of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report
title_full Anti-neutrophil extracellular trap antibody in a patient with relapse of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report
title_fullStr Anti-neutrophil extracellular trap antibody in a patient with relapse of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report
title_full_unstemmed Anti-neutrophil extracellular trap antibody in a patient with relapse of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report
title_short Anti-neutrophil extracellular trap antibody in a patient with relapse of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report
title_sort anti-neutrophil extracellular trap antibody in a patient with relapse of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013953/
https://www.ncbi.nlm.nih.gov/pubmed/29929470
http://dx.doi.org/10.1186/s12882-018-0953-y
work_keys_str_mv AT shidaharuki antineutrophilextracellulartrapantibodyinapatientwithrelapseofantineutrophilcytoplasmicantibodyassociatedvasculitisacasereport
AT hashimotonobuhiro antineutrophilextracellulartrapantibodyinapatientwithrelapseofantineutrophilcytoplasmicantibodyassociatedvasculitisacasereport
AT kusunokiyoshihiro antineutrophilextracellulartrapantibodyinapatientwithrelapseofantineutrophilcytoplasmicantibodyassociatedvasculitisacasereport
AT hattandafumihiko antineutrophilextracellulartrapantibodyinapatientwithrelapseofantineutrophilcytoplasmicantibodyassociatedvasculitisacasereport
AT ogawayayoi antineutrophilextracellulartrapantibodyinapatientwithrelapseofantineutrophilcytoplasmicantibodyassociatedvasculitisacasereport
AT hayashiterumasa antineutrophilextracellulartrapantibodyinapatientwithrelapseofantineutrophilcytoplasmicantibodyassociatedvasculitisacasereport
AT nakazawadaigo antineutrophilextracellulartrapantibodyinapatientwithrelapseofantineutrophilcytoplasmicantibodyassociatedvasculitisacasereport
AT masudasakiko antineutrophilextracellulartrapantibodyinapatientwithrelapseofantineutrophilcytoplasmicantibodyassociatedvasculitisacasereport
AT tomaruutano antineutrophilextracellulartrapantibodyinapatientwithrelapseofantineutrophilcytoplasmicantibodyassociatedvasculitisacasereport
AT ishizuakihiro antineutrophilextracellulartrapantibodyinapatientwithrelapseofantineutrophilcytoplasmicantibodyassociatedvasculitisacasereport